Deep intronic variant in MVK as a cause for mevalonic aciduria initially presenting as non-syndromic retinitis pigmentosa.

MVK RNA splicing cryptic exon deep intronic variant mevalonate kinase deficiency retinitis pigmentosa syndrome

Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
Dec 2022
Historique:
revised: 25 07 2022
received: 07 05 2022
accepted: 27 07 2022
pubmed: 3 8 2022
medline: 4 11 2022
entrez: 2 8 2022
Statut: ppublish

Résumé

Non-syndromic retinitis pigmentosa (NSRP) is a clinically and genetically heterogeneous group of disorders characterized by progressive degeneration of the rod and cone photoreceptors, often leading to blindness. The evolving association of syndromic genes to cause NSRP and the increasing role of intronic variants in explaining missing heritability in genetic disorders present challenges in establishing conclusive clinical and genetic diagnoses. This study sought to identify and validate the causative genetic variant(s) in a 13-year-old male initially diagnosed with NSRP. Genome sequencing identified a pathogenic missense variant in MVK [NM_000431.3:c.803T>C (p.Ile268Thr)], in trans with a novel intronic variant predicted to create a new donor splice site (c.768+71C>A). Proband cDNA analysis confirmed the inclusion of the first 68 base pairs of intron 8 that resulted in a frameshift in MVK (r.768_769ins[768+1_768+68]) and significantly reduced the expression of reference transcript (17.6%). Patient re-phenotyping revealed ataxia, cerebellar atrophy, elevated urinary mevalonate and LTE

Identifiants

pubmed: 35916082
doi: 10.1111/cge.14207
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

524-529

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795-1809.
Verbakel SK, van Huet RAC, Boon CJF, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res. 2018;66:157-186.
Favier LA, Schulert GS. Mevalonate kinase deficiency: current perspectives. Appl Clin Genet. 2016;9:101-110.
Roosing S, Collin RWJ, den Hollander AI, Cremers FPM, Siemiatkowska AM. Prenylation defects in inherited retinal diseases. J Med Genet. 2014;51(3):143-151.
Houten SM, Kuis W, Duran M, et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet. 1999;22(2):175-177.
Drenth JP, Cuisset L, Grateau G, et al. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet. 1999;22(2):178-181.
Hoffmann GF, Charpentier C, Mayatepek E, et al. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics. 1993;91(5):915-921.
van der Burgh R, ter Haar NM, Boes ML, Frenkel J. Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol. 2013;147(3):197-206.
Siemiatkowska AM, van den Born LI, van Hagen PM, et al. Mutations in the mevalonate kinase (MVK) gene cause nonsyndromic retinitis pigmentosa. Ophthalmology. 2013;120(12):2697-2705.
Kellner U, Stöhr H, Weinitz S, Farmand G, Weber BHF. Mevalonate kinase deficiency associated with ataxia and retinitis pigmentosa in two brothers with MVK gene mutations. Ophthalmic Genet. 2017;38(4):340-344.
Balgobind B, Wittebol-Post D, Frenkel J. Retinitis pigmentosa in mevalonate kinase deficiency. J Inherit Metab Dis. 2005;28(6):1143-1145.
Wilker SC, Dagnelie G, Goldberg MF. Retinitis pigmentosa and punctate cataracts in mevalonic aciduria. Retin Cases Brief Rep. 2010;4(1):34-36.
Prietsch V, Mayatepek E, Krastel H, et al. Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics. 2003;111(2):258-261.
Simon A, Kremer HPH, Wevers RA, et al. Mevalonate kinase evidence for a phenotypic continuum. Neurology. 2004;62(6):994-997.
Brennenstuhl H, Nashawi M, Schröter J, et al. Phenotypic diversity, disease progression, and pathogenicity of MVK missense variants in mevalonic aciduria. J Inherit Metab Dis. 2021;44(5):1272-1287.
Gonzalez-Del Pozo M, Fernández-Suárez E, Martín-Sánchez M, et al. Unmasking retinitis pigmentosa complex cases by a whole genome sequencing algorithm based on open-access tools: hidden recessive inheritance and potential oligogenic variants. J Transl Med. 2020;18(1):73.
Meienberg J, Bruggmann R, Oexle K, Matyas G. Clinical sequencing: is WGS the better WES? Hum Genet. 2016;135(3):359-362.
Di Scipio M, Tavares E, Deshmukh S, et al. Phenotype driven analysis of whole genome sequencing identifies deep intronic variants that cause retinal dystrophies by aberrant exonization. Invest Ophthalmol Vis Sci. 2020;61(10):36.
de Bruijn SE, Fiorentino A, Ottaviani D, et al. Structural variants create new topological-associated domains and ectopic retinal enhancer-gene contact in dominant retinitis pigmentosa. Am J Hum Genet. 2020;107(5):802-814.
Tavares E, Tang CY, Vig A, et al. Retrotransposon insertion as a novel mutational event in Bardet-Biedl syndrome. Mol Genet Genomic Med. 2019;7(2):e00521.
Belkadi A, Bolze A, Itan Y, et al. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proc Natl Acad Sci USA. 2015;112(17):5473-5478.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424.
Elhani I, Hentgen V, Grateau G, Georgin-Lavialle S. Neurological manifestations in mevalonate kinase deficiency: a systematic review. Mol Genet Metab. 2022;136(2):85-93.
Maquat LE. Nonsense-mediated mRNA decay in mammals. J Cell Sci. 2005;118(Pt 9):1773-1776.
Poll-The BT, Frenkel J, Houten SM, et al. Mevalonic aciduria in 12 unrelated patients with hyperimmunoglobulinaemia D and periodic fever syndrome. J Inherit Metab Dis. 2000;23(4):363-366.
Jeyaratnam J, Jeyaratnam J, Ter Haar NM, et al. Diagnostic value of urinary mevalonic acid excretion in patients with a clinical suspicion of mevalonate kinase deficiency (MKD). JIMD Rep. 2016;27:33-38.
Mayatepek E, Hoffmann GF, Bremer HJ. Enhanced urinary excretion of leukotriene E4 in patients with mevalonate kinase deficiency. J Pediatr. 1993;123(1):96-98.
Frenkel J, Willemsen MAAP, Weemaes CMR, Dorland L, Mayatepek E. Increased urinary leukotriene E(4) during febrile attacks in the hyperimmunoglobulinaemia D and periodic fever syndrome. Arch Dis Child. 2001;85(2):158-159.
Cuisset L, Drenth JP, Simon A, et al. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet. 2001;9(4):260-266.
Boursier G, Rittore C, Milhavet F, Cuisset L, Touitou I. Mevalonate kinase-associated diseases: hunting for phenotype-genotype correlation. J Clin Med. 2021;10(8):1552.
Steiner LA, Ehrenkranz RA, Peterec SM, Steiner RD, Reyes-Múgica M, Gallagher PG. Perinatal onset mevalonate kinase deficiency. Pediatr Dev Pathol. 2011;14(4):301-306.
Houten SM, Romeijn GJ, Koster J, et al. Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis. Hum Mol Genet. 1999;8(8):1523-1528.
den Hollander AI, Koenekoop RK, Yzer S, et al. Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. Am J Hum Genet. 2006;79(3):556-561.
Ku CA, Hull S, Arno G, et al. Detailed clinical phenotype and molecular genetic findings in CLN3-associated isolated retinal degeneration. JAMA Ophthalmol. 2017;135(7):749-760.
van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008;87(6):301-310.
Hoffmann GF, Sweetman L, Bremer HJ, et al. Facts and artefacts in mevalonic aciduria: development of a stable isotope dilution GCMS assay for mevalonic acid and its application to physiological fluids, tissue samples, prenatal diagnosis and carrier detection. Clin Chim Acta. 1991;198(3):209-227.
Pittler SJ, Fliesler SJ, Fisher PL, Keller PK, Rapp LM. In vivo requirement of protein prenylation for maintenance of retinal cytoarchitecture and photoreceptor structure. J Cell Biol. 1995;130(2):431-439.

Auteurs

Anna Dvaladze (A)

Genetics and Genome Biology, The Hospital for Sick Children (HSC), Toronto, Canada.

Erika Tavares (E)

Genetics and Genome Biology, The Hospital for Sick Children (HSC), Toronto, Canada.

Matteo Di Scipio (M)

Genetics and Genome Biology, The Hospital for Sick Children (HSC), Toronto, Canada.

Graeme Nimmo (G)

Clinical and Metabolic Genetics, HSC, Toronto, Canada.
Fred A Litwin Family Centre for Genetic Medicine, The University Health Network, Toronto, Canada.

Monika K Grudzinska-Pechhacker (MK)

Genetics and Genome Biology, The Hospital for Sick Children (HSC), Toronto, Canada.
Department of Ophthalmology and Vision Sciences, HSC and University of Toronto, Toronto, Canada.

Tara Paton (T)

The Centre for Applied Genomics, HSC, Toronto, Canada.

Anupreet Tumber (A)

Department of Ophthalmology and Vision Sciences, HSC and University of Toronto, Toronto, Canada.

Shuning Li (S)

Genetics and Genome Biology, The Hospital for Sick Children (HSC), Toronto, Canada.

Christabel Eileen (C)

Genetics and Genome Biology, The Hospital for Sick Children (HSC), Toronto, Canada.

Birgit Ertl-Wagner (B)

Division of Neuroradiology, HSC, Toronto, Canada.
Department of Medical Imaging, University of Toronto, Toronto, Canada.

Eva Mamak (E)

Department of Psychology, HSC, Toronto, Canada.

Georg Hoffmann (G)

Neuropaediatrics and Paediatric Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Christian R Marshall (CR)

Division of Genome Diagnostics, HSC, Toronto, Canada.

Dorothea Haas (D)

Neuropaediatrics and Paediatric Metabolic Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Ertan Mayatepek (E)

Department of General Paediatrics, Neonatology and Paediatric Cardiology, University Children's Hospital, Heinrich Heine University, Dusseldorf, Germany.

Andreas Schulze (A)

Clinical and Metabolic Genetics, HSC, Toronto, Canada.
Department of Paediatrics, University of Toronto, Toronto, Canada.
Department of Biochemistry, University of Toronto, Toronto, Canada.

Elise Heon (E)

Genetics and Genome Biology, The Hospital for Sick Children (HSC), Toronto, Canada.
Department of Ophthalmology and Vision Sciences, HSC and University of Toronto, Toronto, Canada.

Ajoy Vincent (A)

Genetics and Genome Biology, The Hospital for Sick Children (HSC), Toronto, Canada.
Department of Ophthalmology and Vision Sciences, HSC and University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH